These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Role of insulin-like growth factor I in the development of diabetic retinopathy]. Gacka M; Adamiec J Przegl Lek; 2003; 60(9):588-92. PubMed ID: 15065339 [TBL] [Abstract][Full Text] [Related]
28. Increasing urine albumin excretion is associated with growth hormone hypersecretion and reduced clearance of insulin in adolescents and young adults with type 1 diabetes: the Oxford Regional Prospective Study. Amin R; Williams RM; Frystyk J; Umpleby M; Matthews D; Orskov H; Dalton RN; Dunger DB Clin Endocrinol (Oxf); 2005 Feb; 62(2):137-44. PubMed ID: 15670188 [TBL] [Abstract][Full Text] [Related]
29. Growth hormone in obesity and diabetes: inappropriate hypothalamic control of secretion. Martin RJ; Jeanrenaud B Int J Obes; 1985; 9 Suppl 1():99-104. PubMed ID: 3905652 [TBL] [Abstract][Full Text] [Related]
30. [Possible role of growth hormone in vascular complications of diabetes]. Canivet J Journ Annu Diabetol Hotel Dieu; 1978; ():217-25. PubMed ID: 651098 [No Abstract] [Full Text] [Related]
31. Free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 (IGFBP-1), and IGFBP-3 and their relationships to the presence of diabetic retinopathy and glomerular hyperfiltration in insulin-dependent diabetes mellitus. Janssen JA; Jacobs ML; Derkx FH; Weber RF; van der Lely AJ; Lamberts SW J Clin Endocrinol Metab; 1997 Sep; 82(9):2809-15. PubMed ID: 9284701 [TBL] [Abstract][Full Text] [Related]
33. [Growth hormone, insulin-like growth factor and insulin-like growth factor binding protein in young type I diabetes patients with the onset of diabetic angiopathy]. Peczyńska J; Urban M; Głowińska B; Urban B Pol Merkur Lekarski; 2003 Apr; 14(82):336-9. PubMed ID: 12868196 [TBL] [Abstract][Full Text] [Related]
34. Hypopituitarism stabilizes the renal and retinal complications of diabetes mellitus. Plumb M; Nath K; Seaquist ER Am J Nephrol; 1992; 12(4):265-7. PubMed ID: 1481875 [TBL] [Abstract][Full Text] [Related]
35. [Is there a possible role of a growth hormone hypersecretion in the course of the vascular complications of diabetes mellitus?]. Lundbaek K Journ Annu Diabetol Hotel Dieu; 1972; 13(0):161-72. PubMed ID: 4605760 [No Abstract] [Full Text] [Related]
36. Diabetes mellitus secondary to chronic pancreatitis. Larsen S Dan Med Bull; 1993 Apr; 40(2):153-62. PubMed ID: 8495594 [TBL] [Abstract][Full Text] [Related]
37. Human growth hormone as a regulator of blood glucose concentration and as a diabetogenic substance. Luft R; Cerasi E Diabetologia; 1968 Jan; 4(1):1-9. PubMed ID: 5741523 [No Abstract] [Full Text] [Related]
38. [Is hypersecretion of growth hormone involved in the onset of essential diabetes mellitus?]. Tchobroutsky G Journ Annu Diabetol Hotel Dieu; 1972; 13(0):153-9. PubMed ID: 4605759 [No Abstract] [Full Text] [Related]
39. [The role of growth hormone in the development of complications in insulin-dependent diabetes]. Krawczuk-Rybak M; Urban M Padiatr Grenzgeb; 1991; 30(3):237-43. PubMed ID: 2067873 [TBL] [Abstract][Full Text] [Related]
40. Rationale for inhibition of growth hormone secretion in the management of the diabetic patient. Gerich JE Scand J Gastroenterol Suppl; 1986; 119():154-7. PubMed ID: 2876500 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]